Rhythm Pharmaceuticals In... (RYTM)

RYTM trades at $99.02, 4.2% above the near-term max pain of $95 expiring Oct 17, 2025 (12 days). Price stability likely with balanced options positioning at this level. Max pain is falling across expirations ($50-$95), signaling increased put positioning or downside protection. Key magnetic zone at 95 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for RYTM shows a downward trend from 95 to 50, indicating bearish sentiment or hedging activity. The 56% spread signals divergent expectations across timeframes. Most levels below 99.02 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.